Thirty-seven patients with advanced or recurrent lung cancer were randomized to cytoxan (CTX) alone, COMF (CTX, oncovin, methotrexate and 5-FU) or AMCOF (adriamycin, methotrexate, CTX, oncovin and 5-FU) after receiving radiation therapy to primary and bulky tumor sites. Median survival was 3 months
Acute effects of combined photodynamic therapy and hyperbaric oxygenation in lung cancer—A clinical pilot study
✍ Scribed by Florian Tomaselli; Alfred Maier; Oliver Sankin; Udo Anegg; Ulrike Stranzl; Hans Pinter; Karin Kapp; Freyja Maria Smolle-Jüttner
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 119 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0196-8092
- DOI
- 10.1002/lsm.1067
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background and Objective
Photodynamic tumor therapy (PDT) is based upon a photochemical reaction that is limited by the availability of molecular oxygen in the target tissue. The use of hyperbaric oxygenation (HBO) increases the amount of oxygen available for the process may thereby enhance the efficacy of PDT. We investigated the acute effects on tumor stenosis after combined PDT/HBO.
Patients and Methods
Thirty patients (22 males, 8 females, mean age: 68.8 years; range: 44–78 years) with inoperable non‐small cell bronchogenic carcinoma and endobronchial stenosis were studied prospectively. Photosensitization was carried out using a hematoporphyrin‐derivative 2 mg/kg BW 48 hours prior to PDT. The light dose was calculated as 300 J/cm fiber tip. The assessment of outcome 1 and 4 weeks after PDT/HBO was performed by endoscopy, chest X‐ray, spirometry, laboratory parameters, subjective report of dyspnea, and Karnofsky performance status.
Results
At one and four weeks after the treatment, the patients felt a significant improvement of dyspnea and hemoptysis along with an objective subsiding of poststenotic pneumonia, though spirometric parameters revealed no significant difference. A significant reduction of tumor stenosis (P < 0.05) and an improvement of the Karnofsky performance status (P < 0.05) were documented 1 and 4 weeks after PDT/HBO. No therapy related complications were observed.
Conclusions
Although the small number of patients does not allow to draw definitive conclusions to be drawn, the results suggests that combined PDT/HBO represents a new, safe, and technically feasible approach. It enables efficient and rapid reduction of the endoluminal tumor load and helps conditioning the patient for further treatment procedures. Lasers Surg. Med. 39:399–403, 2001. © 2001 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Background: Pemetrexed disodium (alimta [eli lilly and company, indianapolis, in], ly231514, multitargeted antifolate) is a new multitargeted antifolate agent that inhibits multiple enzymes in the folate pathway. phase ii trials showed single-agent response rates of 16% and 23% in untreated pati